Psychedelic Bulletin #143: Trademark Filing Reveals Potential Brand Name for MDMA;...

PT431 – The Concept of Integration and the Need for Evolving...

Apex Labs announces the appointment of Chief Medical Officer & Chief...

Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Silo Pharma Engages Clarivate for Intellectual Property and Patent Management

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational...

Exploring the Vast Potential of Psychedelic Medicine: A Physician’s Perspective on...

Numinus to Participate in a Water Tower Research Fireside Chat on...

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study...

PT430 – Psychedelics for Eating Disorders, Davos’ House of Psychedelics, and...

Load more